Literature DB >> 18201778

Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis.

Alicja Wiercinska-Drapalo1, Jerzy Jaroszewicz, Ewa Siwak, Joanna Pogorzelska, Danuta Prokopowicz.   

Abstract

BACKGROUND: One of nine types of FABP, intestinal fatty acid binding protein (I-FABP) is primarily limited to the mature enterocytes of the small intestine, with only trace amounts identified in the stomach and large intestine. The aim of this study was to investigate the use of I-FABP as a possible plasma marker of intestinal injury in patients with ulcerative colitis (UC).
MATERIAL AND METHODS: The study group consisted of 42 patients (11 females and 31 males) with active ulcerative colitis (UC), aged from 24 to 74 years (mean age: 41.8+/-3.5 years). Plasma I-FABP concentrations and hsCRP were compared using endoscopic pictures scored according to the system developed by Meyers et al., and analysed in the context of inflammatory process extension: pancolitis, or distal or left side colitis.
RESULTS: The mean serum I-FABP concentration /mL), whereas individuals with left-side colitis had a mean I-FABP concentration of 61.8+/-8.5 pg/mL. Significant serum I-FABP elevation was observed in UC patients with a severe form of the disease, in contrast to the serum I-FABP concentration in patients with the mild form (260.5+/-60.6 vs. 61.5+/-7.9 pg/mL).
CONCLUSION: The elevated serum I-FABP concentration in patients with UC may indicate ileitis. I-FABP may be a useful marker of the extended inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18201778     DOI: 10.1016/j.regpep.2007.12.002

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  22 in total

Review 1.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

2.  Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis.

Authors:  Katherine E Gregory; Abigail B Winston; Hidemi S Yamamoto; Hassan Y Dawood; Titilayo Fashemi; Raina N Fichorova; Linda J Van Marter
Journal:  J Pediatr       Date:  2014-03-15       Impact factor: 4.406

3.  Brief Report: Gut Structural Damage: an Ongoing Process in Chronically Untreated HIV Infection.

Authors:  Vanessa El Kamari; Abdus Sattar; Grace A Mccomsey
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

4.  Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study.

Authors:  Tatsuo Kanda; Akihiro Tsukahara; Kyo Ueki; Yasuo Sakai; Tatsuo Tani; Atsushi Nishimura; Toshiyuki Yamazaki; Yoichi Tamiya; Tetsuya Tada; Masaki Hirota; Jun Hasegawa; Hiroyuki Funaoka; Hiroshi Fujii; Katsuyoshi Hatakeyama
Journal:  J Gastroenterol       Date:  2011-02-05       Impact factor: 7.527

Review 5.  Diagnosis and management of splanchnic ischemia.

Authors:  Jeroen-J Kolkman; Marloes Bargeman; Ad-B Huisman; Robert-H Geelkerken
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

6.  Clinical significance of FABP2 expression in newborns with necrotizing enterocolitis.

Authors:  Yu Liu; Liang-Fu Jiang; Rong-Peng Zhang; Wen-Tong Zhang
Journal:  World J Pediatr       Date:  2015-11-07       Impact factor: 2.764

Review 7.  The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases.

Authors:  Shaun S C Ho; Jacqueline I Keenan; Andrew S Day
Journal:  Dig Dis Sci       Date:  2019-09-16       Impact factor: 3.199

8.  Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy.

Authors:  Jan Vesterbacka; Piotr Nowak; Babilonia Barqasho; Samir Abdurahman; Jessica Nyström; Staffan Nilsson; Hiroyuki Funaoka; Tatsuo Kanda; Lars-Magnus Andersson; Magnus Gisslèn; Anders Sönnerborg
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

9.  Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy.

Authors:  Natalia M Bottasso Arias; Marina García; Constanza Bondar; Luciana Guzman; Agustina Redondo; Nestor Chopita; Betina Córsico; Fernando G Chirdo
Journal:  Mediators Inflamm       Date:  2015-08-05       Impact factor: 4.711

10.  Post-infectious and non post-infectious irritable bowel syndrome: A comparative study.

Authors:  Jianbo Wang; Shihua Lu; Shijie Zhao
Journal:  Pak J Med Sci       Date:  2016 Jan-Feb       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.